Abstract:Infections that result in natural or manmade spread of lethal biological agents are a concern and require national and focused preparedness. In this manuscript, as part of an early diagnostics and pathogen treatment strategy, we have focused on extracellular vesicles (EVs) that arise following infections. Although the field of biodefense does not currently have a rich resource in EVs literature, none the less, similar pathogens belonging to the more classical emerging and non-emerging diseases have been studied in their EV/exosomal contents and function. These exosomes are formed in late endosomes and released from the cell membrane in almost every cell type in vivo. These vesicles contain proteins, RNA, and lipids from the cells they originate from and function in development, signal transduction, cell survival, and transfer of infectious material. The current review focuses on how different forms of infection exploit the exosomal pathway and how exosomes can be exploited artificially to treat infection and disease and potentially also be used as a source of vaccine. Virally-infected cells can secrete viral as well as cellular proteins and RNA in exosomes, allowing viruses to cause latent infection and spread of miRNA to nearby cells prior to a subsequent infection. In addition to virally-infected host cells, bacteria, protozoa, and fungi can all release small vesicles that contain pathogen-associated molecular patterns, regulating the neighboring uninfected cells. Examples of exosomes from both virally and bacterially infected cells point toward a re-programming network of pathways in the recipient cells. Finally, many of these exosomes contain cytokines and miRNAs that in turn can effect gene expression in the recipient cells through the classical toll-like receptor and NFκB pathway. Therefore, although exosomes do not replicate as an independent entity, they however facilitate movement of infectious material through tissues and may be the cause of many pathologies seen in infected hosts.

Extracellular vesicles in virus infection and pathogenesis

Extracellular Vesicles: A Novel Mode of Viral Propagation Exploited by Enveloped and Non-Enveloped Viruses

Extracellular Vesicles in Pathogenic Infection, Transmission, and Immunity

Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications

Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics

Extracellular Vesicles Regulated by Viruses and Antiviral Strategies.

Extracellular vesicles from infected cells: potential for direct pathogenesis

Emerging roles of extracellular vesicles in mediating RNA virus infection

Extracellular Vesicles: Recent Insights Into the Interaction Between Host and Pathogenic Bacteria

Host innate immune systems gather intel on invading microbes via pathogen-derived extracellular vesicles

Extracellular vesicles biogenesis and uptake concepts: A comprehensive guide to studying host-pathogen communication

Extracellular vesicles and infectious diseases: new complexity to an old story

Biogenesis of extracellular vesicles from the pathogen perspective: Transkingdom strategies for delivering messages

Extracellular Vesicle-Mediated Communication Within Host-Parasite Interactions

Extracellular vesicles in the pathogenesis of neurotropic viruses

Biogenesis and Biological Functions of Extracellular Vesicles in Cellular and Organismal Communication With Microbes

The Role of Extracellular Vesicles in Pandemic Viral Infections

Focus on Extracellular Vesicles: Introducing the Next Small Big Thing

Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential

Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic?

The Ambiguous Roles of Extracellular Vesicles in HIV Replication and Pathogenesis